Severe Eosinophilic Asthma

2

Review clinical trials related to Severe Eosinophilic Asthma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma

An open-label study will evaluate effects of Depemokimab in the treatment of severe eosinophilic asthma in patients with allergic bronchopulmonary aspergillosis

Participants needed: 10
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Qianfoshan HospitalUpdated: Sep 24, 2026Locations: 1
Eligibility criteria

Female and Male patients aged 18-75 years [+2]

History of allergy or hypersensitivity reaction to Depemokimab or any of its com... [+2]

Status: Recruiting

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

This is an observational, multicenter, prospective study on patients with severe eosinophilic asthma treated with benralizumab aimed at evaluating the achievement of partial and complete clinical remission.

Participants needed: 335
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: AstraZenecaUpdated: Sep 18, 2026Locations: 28
Eligibility criteria

Adults (≥ 18 years old) diagnosed with severe uncontrolled eosinophilic asthma. [+3]

Benralizumab treatment within the 12 months prior to study enrollment and up to... [+5]